Medis

With our deep understanding of local healthcare systems, we can support innovative global biotech and pharma companies to leave significant footprint in the complex markets of CEE in compliance with the highest industry standards. We strongly believe that all patients should have equal opportunities and access to the best available treatment options. Our 400 global team members are united in responsibility to support them on their journey. Our advantages: • Full commercialization through a single point of contact and delivery • Deep understanding of local healthcare systems • Direct local presence through our companies • Highest standards of ethics and compliance matching that of our partners Medis is a member of the World Orphan Drug Alliance (WODA): World Orphan Drug Alliance (WODA) is a global alliance of full-service regional distributors. WODA provides full-service solution to pharmaceutical & biotech companies with a portfolio of rare diseases, oncology and highly specialized therapeutics, starting from named patient programs to full commercialization. WODA covers 68 countries in the following regions: • Central and Eastern Europe (Medis) • Latin America (OrphanDC) • Middle East, North Africa & Turkey (Vector Pharma) • Russia & the CIS region (Orpharm) • Switzerland (EffRx Pharmaceuticals) Major Partners: Besins, Biogen, Biotest, Johnson&Johnson, Merz, Mundipharma, PTC Therapeutics, Pierre Fabre, Santen, UCB, Pleuran, Ricerfarma, UP Medi Europa, Abbott, Aesculap, Asahi Medical, B. Braun, Cytosorbents, Biotest, Zimmer MedizinSysteme Get in touch with us: [email protected] T: +386 1 600 22 42